☰

Michael Belshan - Publications

Affiliations: 
Medical Microbiology and Immunology Creighton University, Omaha, NE, United States 
Area:
Immunology, Microbiology Biology, Cell Biology
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Mandal S, Sunagawa SW, Prathipati PK, Belshan M, Shibata A, Destache CJ. Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study. Nanomaterials (Basel, Switzerland). 12. PMID 35683795 DOI: 10.3390/nano12111942  0.512
2021 Macur K, Zieschang S, Lei S, Morsey B, Jaquet S, Belshan M, Fox HS, Ciborowski P. SWATH-MS and MRM: Quantification of Ras-related proteins in HIV-1 infected and methamphetamine-exposed human monocyte-derived macrophages (hMDM). Proteomics. e2100005. PMID 34051048 DOI: 10.1002/pmic.202100005  0.526
2021 Belshan M, Holbrook A, George JW, Durant HE, Callahan M, Jaquet S, West JT, Siedlik J, Ciborowski P. Discovery of candidate HIV-1 latency biomarkers using an OMICs approach. Virology. 558: 86-95. PMID 33735754 DOI: 10.1016/j.virol.2021.03.003  0.573
2019 Holbrook AK, Peterson HD, Bianchi SA, Macdonald BW, Bredahl EC, Belshan M, Siedlik JA. CD4 T cell activation and associated susceptibility to HIV-1 infection in vitro increased following acute resistance exercise in human subjects. Physiological Reports. 7: e14234. PMID 31552706 DOI: 10.14814/Phy2.14234  0.402
2019 Mandal S, Prathipati PK, Belshan M, Destache CJ. A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study. Antiviral Research. PMID 30991088 DOI: 10.1016/J.Antiviral.2019.04.007  0.488
2018 DeBoer J, Wojtkiewicz MS, Haverland N, Li Y, Harwood E, Leshen E, George JW, Ciborowski P, Belshan M. Proteomic profiling of HIV-infected T-cells by SWATH mass spectrometry. Virology. 516: 246-257. PMID 29425767 DOI: 10.1016/j.virol.2018.01.025  0.626
2018 Holbrook AK, Belshan MA, Bredahl EC, Siedlik JA. The Effect Of Exercise On CD4+ T-cell Activation And Their Susceptibility To HIV-1 Medicine & Science in Sports & Exercise. 50: 224. DOI: 10.1249/01.mss.0000535825.01047.15  0.384
2016 Mandal S, Belshan M, Holec A, Zhou Y, Destache CJ. An enhanced Emtricitabine loaded long-acting nano-formulation for prevention or treatment of HIV infection. Antimicrobial Agents and Chemotherapy. PMID 27821449 DOI: 10.1128/Aac.01475-16  0.533
2016 Li Y, Belshan M. NF45 and NF90 Bind HIV-1 RNA and Modulate HIV Gene Expression. Viruses. 8. PMID 26891316 DOI: 10.3390/V8020047  0.582
2016 DeBoer J, Madson CJ, Belshan M. Cyclophilin B enhances HIV-1 infection. Virology. 489: 282-91. PMID 26774171 DOI: 10.1016/J.Virol.2015.12.015  0.673
2016 Li Y, Frederick KM, Haverland NA, Ciborowski P, Belshan M. Investigation of the HIV-1 matrix interactome during virus replication. Proteomics. Clinical Applications. 10: 156-63. PMID 26360636 DOI: 10.1002/Prca.201400189  0.65
2015 Kovarova M, Council OD, Date AA, Long JM, Nochi T, Belshan M, Shibata A, Vincent H, Baker CE, Thayer WO, Kraus G, Lachaud-Durand S, Williams P, Destache CJ, Garcia JV. Correction: Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission. Plos Pathogens. 11: e1005170. PMID 26474397 DOI: 10.1371/Journal.Ppat.1005170  0.537
2015 Date AA, Shibata A, McMullen E, La Bruzzo K, Bruck P, Belshan M, Zhou Y, Destache CJ. Thermosensitive Gel Containing Cellulose Acetate Phthalate-Efavirenz Combination Nanoparticles for Prevention of HIV-1 Infection. Journal of Biomedical Nanotechnology. 11: 416-27. PMID 26307825 DOI: 10.1166/Jbn.2015.1942  0.515
2015 Kovarova M, Council OD, Date AA, Long JM, Nochii T, Belshan M, Shibata A, Vincent H, Baker CE, Thayer WO, Kraus G, Lachaud-Durand S, Williams P, Destache CJ, Garcia JV. Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission. Plos Pathogens. 11: e1005075. PMID 26271040 DOI: 10.1371/Journal.Ppat.1005075  0.617
2014 DeBoer J, Jagadish T, Haverland NA, Madson CJ, Ciborowski P, Belshan M. Alterations in the nuclear proteome of HIV-1 infected T-cells. Virology. 468: 409-20. PMID 25240327 DOI: 10.1016/J.Virol.2014.08.029  0.67
2014 Sanford B, Li Y, Maly CJ, Madson CJ, Chen H, Zhou Y, Belshan M. Deletions in the fifth alpha helix of HIV-1 matrix block virus release. Virology. 468: 293-302. PMID 25217711 DOI: 10.1016/j.virol.2014.08.017  0.379
2013 Gérard A, Soler N, Ségéral E, Belshan M, Emiliani S. Identification of low molecular weight nuclear complexes containing integrase during the early stages of HIV-1 infection. Retrovirology. 10: 13. PMID 23369367 DOI: 10.1186/1742-4690-10-13  0.685
2013 Shibata A, McMullen E, Pham A, Belshan M, Sanford B, Zhou Y, Goede M, Date AA, Date AA, Destache CJ. Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment. Aids Research and Human Retroviruses. 29: 746-54. PMID 23289671 DOI: 10.1089/Aid.2012.0301  0.468
2013 Schweitzer CJ, Jagadish T, Haverland N, Ciborowski P, Belshan M. Proteomic analysis of early HIV-1 nucleoprotein complexes. Journal of Proteome Research. 12: 559-72. PMID 23282062 DOI: 10.1021/Pr300869H  0.69
2012 Schweitzer CJ, Matthews JM, Madson CJ, Donnellan MR, Cerny RL, Belshan M. Knockdown of the cellular protein LRPPRC attenuates HIV-1 infection. Plos One. 7: e40537. PMID 22808186 DOI: 10.1371/Journal.Pone.0040537  0.699
2012 Belshan M, Kimata JT, Brown C, Cheng X, McCulley A, Larsen A, Thippeshappa R, Hodara V, Giavedoni L, Hirsch V, Ratner L. Vpx is critical for SIVmne infection of pigtail macaques. Retrovirology. 9: 32. PMID 22531456 DOI: 10.1186/1742-4690-9-32  0.44
2012 Belshan M. HIV Research Beyond the “omics” Era Journal of Virology & Antiviral Research. 1. DOI: 10.4172/2324-8955.1000E105  0.489
2011 Belshan M, Matthews JM, Madson CJ. Replication of biotinylated human immunodeficiency viruses. Journal of Virological Methods. 171: 299-302. PMID 21087640 DOI: 10.1016/J.Jviromet.2010.11.005  0.668
2009 Belshan M, Schweitzer CJ, Donnellan MR, Lu R, Engelman A. In vivo biotinylation and capture of HIV-1 matrix and integrase proteins. Journal of Virological Methods. 159: 178-84. PMID 19490971 DOI: 10.1016/J.Jviromet.2009.03.017  0.685
2008 Cheng X, Belshan M, Ratner L. Hsp40 facilitates nuclear import of the human immunodeficiency virus type 2 Vpx-mediated preintegration complex. Journal of Virology. 82: 1229-37. PMID 18032501 DOI: 10.1128/Jvi.00540-07  0.441
2006 Mahnke LA, Belshan M, Ratner L. Analysis of HIV-2 Vpx by modeling and insertional mutagenesis. Virology. 348: 165-74. PMID 16457868 DOI: 10.1016/J.Virol.2005.12.023  0.417
2006 Belshan M, Mahnke LA, Ratner L. Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells. Virology. 346: 118-26. PMID 16325220 DOI: 10.1016/J.Virol.2005.10.036  0.647
2003 Baccam P, Thompson RJ, Li Y, Sparks WO, Belshan M, Dorman KS, Wannemuehler Y, Oaks JL, Cornette JL, Carpenter S. Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype. Journal of Virology. 77: 12122-31. PMID 14581549 DOI: 10.1128/Jvi.77.22.12122-12131.2003  0.412
2003 Belshan M, Ratner L. Identification of the nuclear localization signal of human immunodeficiency virus type 2 Vpx. Virology. 311: 7-15. PMID 12832198 DOI: 10.1016/S0042-6822(03)00093-X  0.563
Show low-probability matches.